Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

14 trials with published results (21%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.1%

4 terminated out of 66 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

35%

14 of 40 completed with results

Key Signals

14 with results91% success

Data Visualizations

Phase Distribution

50Total
Not Applicable (25)
Early P 1 (2)
P 1 (10)
P 2 (10)
P 3 (1)
P 4 (2)

Trial Status

Completed40
Unknown9
Withdrawn5
Recruiting4
Terminated4
Active Not Recruiting2

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 40 completed trials

Clinical Trials (66)

Showing 20 of 20 trials
NCT04589325Phase 2Active Not RecruitingPrimary

Ixekizumab Diabetes Intervention Trial (I-DIT)

NCT03648918Recruiting

Genetics Of Autoimmunity In Type I Diabetes

NCT07319286Phase 1Enrolling By Invitation

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

NCT03369821RecruitingPrimary

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

NCT04355832Early Phase 1WithdrawnPrimary

Glucagon-like Peptide-1 in Type 1 Diabetes

NCT05777330Not ApplicableRecruitingPrimary

Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes

NCT03945747Active Not RecruitingPrimary

MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus

NCT03738852Early Phase 1CompletedPrimary

Mechanisms for Restoration of Hypoglycemia Awareness

NCT03811470Recruiting

China Diabetes Registry by Metabolic Management Center

NCT06606509Not Yet RecruitingPrimary

The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

NCT03423589Not ApplicableCompleted

Modulation of Type 1 Diabetes Susceptibility Through the Use of Probiotics

NCT03428945Phase 2TerminatedPrimary

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus

NCT03582956Not ApplicableTerminatedPrimary

Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes

NCT03766334Not ApplicableWithdrawnPrimary

Efficacy and Safety of Highland Barley Diet on Glucose Variability in Patients With Type 1 Diabetes Mellitus

NCT03588104Not ApplicableCompletedPrimary

"POWER2DM Evaluation Campaign"

NCT03704818Phase 1CompletedPrimary

Dapagliflozin Effects on Hypoglycemia

NCT06206317UnknownPrimary

Comparison of Motor and Sensory Functions of the Hand in Children With Type 1 Diabetes Mellitus and Their Healthy Peers

NCT03623113Not ApplicableCompleted

The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes

NCT05928260Not ApplicableUnknownPrimary

Comparison of Real-time CGMS With Intermittently-scanned CGMS in Adolescents and Adults With Type 1 Diabetes Mellitus

NCT03117998Phase 2CompletedPrimary

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

Scroll to load more

Research Network

Activity Timeline